CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire•31/07/2026•18:45 ET
0
Whiz Insights
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CareDx, Inc. (Nasdaq: CDNA) — a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today announced that, on July 30, 2026, CareDx granted to James McNally, the Company’s newly appointed Executive Advisor, certain stock awards as an inducement material to Mr. McNally’s employment with CareDx.
Get started
Create a free account to read the full story.